https://timesbeats.com/press-releases/glyconex-announces-japanese-regulatory-submission-for-denosumab-biosimilar-spd8Times Beatsen2026-11-09T01:12:26.890ZGlycoNex Announces Japanese Regulatory Submission for Denosumab Biosimilar SPD8 https://timesbeats.com/press-releases/antengene-presents-latest-preclinical-results-of-novel-cos-tce-platform-antengagerd2-inTimes Beatsen2026-11-09T00:34:29.097ZAntengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026 https://timesbeats.com/press-releases/innovent-announces-phase-3-credit-5-study-met-primary-endpoint-sintbilor-tafolecimabTimes Beatsen2026-11-09T00:25:41.775ZInnovent Announces Phase 3 CREDIT-5 Study Met Primary Endpoint, SINTBILO® (Tafolecimab Injection) as First-line Monotherapy Treatment for Hyperlipidemia Demonstrated Potent Lipid-lowering Efficacy